NCT07162389

Brief Summary

Early Stability of Short vs. Standard Dental Implants in the Posterior Mandible This study compares how well short dental implants (7mm) work compared to standard-length implants (11mm) when placed in the back part of the lower jaw. Both types of implants have special shallow threads designed to reduce stress on the bone. The main goal is to see how stable they are during the first 4 weeks after placement-a critical time for healing.

  • Short implants may be a good option for patients with limited jawbone height, avoiding the need for bone grafting.
  • Understanding their early stability helps dentists decide when it's safe to place teeth on them.
  • This study uses advanced tools like 3D scans (CBCT) and implant stability measurements (ISQ) to track healing. What will happen in the study?
  • Screening: A dental exam and 3D scan to check bone quality.
  • Implant Placement:
  • Short (7mm) or standard (11mm) implant, depending on your bone height.
  • Minimally invasive surgery with local anesthesia.
  • Follow-ups: Painless stability checks at end of 1, 2, 3, and 4 weeks using a small device (RFA).
  • Enough bone width (≥6.5mm).
  • No uncontrolled health conditions (e.g., severe diabetes).
  • Non-smokers or light smokers (\<10 cigarettes/day).
  • Benefits: Free implant placement and monitoring; contributes to better dental care.
  • Risks: Typical surgery risks (swelling, infection); rare nerve injury (\<5% chance). How long is the study?
  • Active participation: 4 weeks (with optional long-term follow-up).
  • Total study duration: \~12 months (including data analysis). Mohammad Abdulwahab Al-Jonaid University of Science and Technology, Sana'a.
  • Supervisor: Dr. Ali Al-Hudaied, Oral and Maxillofacial Surgery Specialist.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

July 18, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

September 9, 2025

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

July 18, 2025

Last Update Submit

September 4, 2025

Conditions

Keywords

RFAISQShort dental implantsShallow-threadedPosterior MandibleEarly Dynamic Changesprimary StabilityStability dip

Outcome Measures

Primary Outcomes (4)

  • Implant Stability Quotient (ISQ) at Baseline (T0)

    Mean Resonance frequency Analysis(RFA) measurement taken immediately post-implantation(T0), to assess primary mechanical stability. ISQ range 1-100, low stability \<60, medium stability 60 to 69, high more than or equal 70. Reported as mean ISQ value per group.

    Measurement at implant placement(Day 0)

  • Insertion Torque value- ITV.

    The rotational torque in Ncm,applied during the final quarter-turn of implant insertion. This is direct measure of primary mechanical stability. Reported as mean ITV per group.

    Measurement at during implant placement (intraoperative)

  • Magnitude of Stability Dip

    The mean lowest point of stability curve , calculated as the greatest negative change in ISQ value from the baseline T0, measurement for each implant during the 4 -week monitoring period.

    from implant placement (Day 0) through week4

  • Time of Onset of Secondary Stability

    The mean time in days post implantation at which the ISQ value begins to consistently increase, indicating the start biological secondary stability. Defined as the time point after the nadir -T2or T3.where the ISQ value shows a positive increase confirmed at the subsequent measurement.

    from Day0 , through week 4.

Study Arms (2)

Short Dental Implant Group.

EXPERIMENTAL

Group A, Shallow-Threaded ,length 7mm, diameter 4.2mm,10 single dental implants.

Device: Shallow-Threaded Short Implant (SHI)Device: Shallow-Threaded Standard Implant (SDI)

Standard Dental Implant Group.

ACTIVE COMPARATOR

Group B, Shallow-Threaded ,length 11mm, diameter 4.2mm,10 single dental implants.

Device: Shallow-Threaded Short Implant (SHI)Device: Shallow-Threaded Standard Implant (SDI)

Interventions

A 7mm long, 4.2mm diameter dental implant with shallow thread (\<0.5mm depth) Macrodesign, surgically placed in the jawbone to restore missing teeth

Short Dental Implant Group.Standard Dental Implant Group.

A 11mm long, 4.2mm diameter dental implant with shallow thread (\<0.5mm depth) macrodesign, surgically placed in the jawbone to restore missing teeth.

Short Dental Implant Group.Standard Dental Implant Group.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \. Adults ≥18 years with partial posterior mandibular edentulism. 2. Bone height ≥7 mm and width \>6 mm (CBCT-confirmed). 3. D2/D3 bone density (HU: 350-1250). 4. Healed posterior mandibular sites (3-6 months post-extraction). 5. Good oral hygiene (plaque index ≤1). 6. Willingness to adhere to study protocols.

You may not qualify if:

  • \. Uncontrolled systemic diseases (e.g., diabetes with HbA1c \>7%, liver disease) or medications affecting bone healing (e.g., corticosteroids, bisphosphonates).
  • \. History of head/neck radiotherapy (with in past year). 3. Heavy smoking (\>10 cigarettes/day). 4. Absolute contraindications for oral surgery (e.g., recent MI/CVA \< 6months, bleeding disorders).
  • \. Active periodontal disease, parafunctional habits as bruxism, or prior bone grafting at the site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

university of Sciences and Technology

Sanaa, 009671, Yemen

Location

MeSH Terms

Conditions

Alveolar Bone Loss

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This clinical trial employs partial masking (blinding) to minimize bias in outcome assessments: 1. Blinded Parties * Outcome Assessors: * The researcher performing resonance frequency analysis (RFA) measurements (ISQ values at T0-T4) is masked to: * Implant length (7mm vs. 11mm) * Insertion torque value (ITV) Rationale: Prevents measurement bias in stability tracking. * Data Analysts: * Statisticians processing ISQ trends are blinded to group allocation until analysis completion. 2. Non-Blinded Parties * Surgeon: Cannot be masked due to visual/tactile differences during osteotomy preparation. * Patients: Aware of implant type due to post-operative healing abutment visibility. 3. Blinding Methods * RFA Protocol: * SmartPeg placement/readings performed by a separate researcher not involved in surgery. * ISQ values recorded using coded forms without implant length details.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Interventional Study A Prospective, controlled, parallel-group, anatomically allocated pilot study . Anatomically-Driven Allocation * Group A (Short Implants): 7mm implants placed in sites with 8.5-9mm residual bone height (measured from crest to inferior alveolar nerve + 1.5mm safety margin). * Group B (Standard Implants): 11mm implants placed in sites with ≥12.5mm bone height. * Rationale: Mimics real-world clinical decision-making where implant length is determined by available bone anatomy. 2\. Technical Controls: * Standardized diameter: All implants 4.2mm (Tiologic Twinfit system). * Identical surface/macrodesign: SLA surface, shallow threads (\<0.5mm depth), reverse-buttress profile. * Surgical calibration: Single operator, under-drilling protocol for D2 bone (final drill -0.2mm), non-condensing drilling for D3 bone. 3\. Dynamic Monitoring Protocol: * Timepoints: T0 immediate, T1,T2,T3,T4 (at the end of weeks- 1,2,3,4)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.Sc Candidate in Oral Surgery and implantology

Study Record Dates

First Submitted

July 18, 2025

First Posted

September 9, 2025

Study Start

August 1, 2025

Primary Completion

February 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 9, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Anonymized data available upon request after publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
6 months from 21/07/2025
Access Criteria
De-identified individual participant data will be made available upon reasonable request to corresponding author . Requests require a methodology sound proposal and a signed data access agreement.

Locations